Stryker Announces Changes to Executive Leadership (press release)
Stryker Corporation (NYSE:SYK) announced today the appointment of David K. Floyd to the role of Group President, Orthopaedics, effective November 15, 2012. Orthopaedics includes the Company's Reconstructive, Trauma and Extremities, Joint Preservation, Orthobiologics and Performance Solutions businesses. Mr. Floyd will report to Kevin A. Lobo, President and Chief Executive Officer of Stryker.
"David brings a strong medical device and orthopaedic perspective to Stryker through his successful leadership roles in a broad range of enterprises, including a venture backed startup, middle market med tech and large cap multinationals. He is a proven leader who has demonstrated the ability to drive profitable growth through innovation and we are delighted to have David join our executive team at Stryker," said Mr. Lobo. Mr. Floyd has successfully managed global businesses through unprecedented industry change while maintaining strong company, regulatory and customer relationships.
Mr. Floyd joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles...
